IFNGR1 and arthritic joint disease: Thus, although anti-IL-17 antibody is effective in reducing the clinical symptoms of arthritis in both IFN-γR KO and wild-type mice, the mechanism of endogenous IL-17 in the pathogenesis of CIA appears to be somewhat different between the two groups of mice.